Wall St futures flat amid US-China trade jitters; bank earnings in focus
CannaPharmaRX, Inc. (OTC:CPMD) reported that it has entered into letter agreements outlining payment schedules to address outstanding amounts due to two significant debtholders. The company disclosed these actions in a filing with the Securities and Exchange Commission.
According to the statement, CannaPharmaRX developed the payment schedules as a means to manage its existing debts and avoid further defaults, while retaining capital to continue operations and product delivery. The company noted that information about the payment schedules was previously included in its quarterly report for the period ending June 30, 2025, but the actual agreements were not attached at that time due to an oversight.
The company is now filing the payment schedule agreements as exhibits to its current report. The repayment schedules relate to amounts owed to A. Tal and Koze Investments, as listed in the filing.
CannaPharmaRX is incorporated in Delaware and is based in Calgary, Alberta, Canada. Its common stock is traded on the OTC Markets under the symbol CPMD.
This information is based on a statement made in a press release and the company’s SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.